Metraipolis › archive › dc_152ca2fbe43a

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort — Europe PMC PMID:42056066

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42056066
DOI: 10.1002/mds.70336
License (as archived): solo-consultazione
Archived: 2026-11-03T01:43:15.310Z
SHA-256 of the archived text: 74f08d73f1c7ae30973c8ab86361b7a52a179d3243467dd0bd03491b001dbfae
Stable URL of this page: https://metraipolis.com/documento/dc_152ca2fbe43a

How to cite

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort — Europe PMC PMID:42056066 — Europe PMC (en), https://europepmc.org/article/MED/42056066 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_152ca2fbe43a (Metraipolis archive dc_152ca2fbe43a, sha256 74f08d73f1c7ae30973c8ab86361b7a52a179d3243467dd0bd03491b001dbfae)

BibTeX

@misc{dc152ca2fbe43a,
  title = {Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort — Europe PMC PMID:42056066},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42056066},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_152ca2fbe43a; sha256 74f08d73f1c7ae30973c8ab86361b7a52a179d3243467dd0bd03491b001dbfae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42056066. Agents can read the archived copy with the MCP tool read_document.